Panel Discussion: Assessing Biopharma Partnership Selection Strategies in Precision Medicine to Strengthen Strategic Partnerships & Accelerate Clinical Success
- What capabilities, compliance, or market experience drive appetite to collaborate with a particular partner? And how do different pharma companies prioritize partner selection considering these criteria?Â
- What is the significance of global partner footprint in the context of co-development and large-scale manufacturing?Â